If your question isn't answered here, please email us at: firstname.lastname@example.org!
CBD is the acronym for Cannabidiol. More recently, CBD is often used generically to refer to the 100+ Cannabinoids extracted from the hemp plant. CBD is a non-psychoactive, non-intoxicating, has no known drug interaction and has a history of use dating back thousands of years.
CBD (Cannabidiol) comes from the hemp plant through an extraction process.
Endocannabinoids are two types of Cannabinoids that activate the body’s Endocannabinoid System and are produced naturally by the body. Phytocannabinoids are Cannabinoids, extracted from the hemp plant, resulting in oils rich in Cannabinoids including CBD, CBN, CBG, and many others. These Cannabinoid oils are formulated into our CBD products.
The Endocannabinoid System or ECS, is a physiologic network found throughout the human body that helps us to maintain homeostasis or wellbeing. The ECS is found in all vertebrates, including mammals, fish, amphibians, reptiles, and birds. Through the signaling or transmission of neurons, the ECS can affect our nervous system, immune system, organs, and other parts of our body. That signaling serves as communication between the body and our brain. The two receptors currently identified in the ECS are CB1, found predominately in our nervous system (brain and spinal cord),and CB2, found throughout our peripheral nervous system such as skin, muscles, limbs, and immune cells. When the receptors are stimulated by Cannabinoids, they transmit information triggering a cellular response which is most suitable to that area of the body. Research has shown that the Endocannabinoid System is involved with sleep, moods, stress, appetite, minor aches and pains, as well as metabolism.
Endogenous cannabinoids, the ones occurring naturally in our body, are only created when we need them. For example, to combat an illness or pain. These Cannabinoids have short-range effects and a short half-life before they are broken down by enzymes through chemical reactions in our bodies. Therefore, it’s beneficial to supplement our natural production of Cannabinoids to help maintain health and wellness, primarily through managing homeostasis. Homeostasis is important because it’s the balance of our cognitive and physiological function. Cannabinoids can help with homeostasis because our bodies are equipped to receive these cannabinoids through the CB1and CB2 receptors creating a positive cascade response. Ongoing research has shown a variety of benefits including reduction in chronic pain, joint pain, anxiety and depression, as well as helping with sleeplessness and headaches. When used topically it may reduce skin inflammation, dry skin, fine lines, and acne.
Full-spectrum CBD is the oil extracted from the hemp plant containing all of the Cannabinoids present, including trace amounts of the Cannabinoid, delta-9-tetrahydrocannabinol (THC). Research indicates the existence of an “entourage effect” with full-spectrum CBD and suggests having trace amounts of THC increases CBD's potential health benefits. Mostly all of our CBD products are formulated with full-spectrum CBD, with the exceptions being our isolate CBD gummies.
Broad-spectrum CBD is the same extracted oil but with the TCH removed through a secondary process.
No, CBD is not psychoactive or intoxicating.
Our products are formulated with full-spectrum CBD and do contain trace amounts amounts of THC, under 0.3%, which is is the Federally legal maximum allowed.
While not likely, there is a slight chance it could show upon a drug test. In the rare case this does happen, explaining the situation to your employer can go a long way. Providing your employer with the Certificate of Analysis’ (COAs) of the our CBD products you are taking can help them understand that you are not using marijuana. You can download KoreLife CBD COAs HERE. Quality and safety is something we take very seriously. All KoreLife CBD products are tested by accredited DEA registered laboratories that verify the quality and safety of all our products. A COA indicates the quantity of cannabinoids found in a product, as well as levels of heavy metals, pesticides, solvents, and THC.
A Certificate of Analysis, or COA, is a document prepared by an accredited independent third-party testing laboratory certifying the potency, purity, quality, and safety of the CBD. A COA indicates the quantity of Cannabinoids (CBD) in the product as well as levels of heavy metals, pesticides, solvents, and THC.
A COA is important because the FDA does not currently regulate CBD products. FDA regulation keeps food and drugs that are harmful or cause serious and perhaps deadly side effects off the market. Regulations also require that companies provide consumers with valid and accurate information about their products, especially about products you ingest or put on your skin. Due to lack of regulation, many CBD products are marketed with false claims and misleading statements such as omitted ingredients and incorrectly stating about the amount of Cannabinoids (CBD) in the product. A COA from an accredited independent third-party laboratory informs the consumer about the CBD product and allows consumers to verify the CBD is safe and contains the amount of Cannabinoids stated on the label.
We take quality and safety very seriously at KoreLife CBD. COA’s for our CBD products can be downloaded HERE.
Cannabinoids (CBD) need to buildup in your system, and be maintained over time. It’s generally regarded that it takes around 1 week for cannabinoids to be completely metabolized in your body. That’s the rule of thumb, but it can take longer. CBD oil works best with continued use – twice a day, taken sublingually by putting the CBD oil under your tongue and allowing it to absorb. Weight and other factors, like any other medications you might be taking, could prolong or shorten the time it takes for your body to metabolize the CBD oil.
At this time, we aren’t selling to the UK. The UK has different regulatory standards than the U.S. and in order for us to sell our products in the UK, we must apply for approval under the UK Food Safety Act. The UK considers CBD to be a novel food. UK hemp and CBD laws are very detailed and have strict requirements. This process of getting novel food approval is similar to applying with the US FDA for novel drug approval. However, KoreLife CBD is planning to expand into international markets as we grow…stay tuned!